4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-20-018817
Chief Scientific Officer sold 2,951 shares at $20.00 ($59,020)
- Chief Scientific Officer acquired 2,951 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…